Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Thum

Showing results (11-20 of 500) with videos related to

Pageof 50
Sort By:
European Heart Journal|July 2, 2020
The ESC Working Group on Myocardial FunctionThomas Thum
Nature Reviews. Cardiology|September 10, 2014
Noncoding RNAs and myocardial fibrosisThomas Thum
European Journal of Heart Failure|August 6, 2016
Novel models and mechanisms of heart failure with preserved ejection fractionThomas Thum
European Heart Journal|January 10, 2018
Refractory angina revisited: stem cells for a growing unmet clinical need?Thomas Thum
Circulation Research|December 7, 2013
MicroRNA-223 made its way into vascular researchThomas Thum
Antioxidants & Redox Signaling|August 18, 2010
Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunctionFelix Fleissner, Thomas Thum
Vascular Medicine (London, England)|February 1, 2006
Spotlight on endothelial progenitor cell inhibitors: short reviewThomas Thum, Johann Bauersachs
The Journal of Biological Chemistry|April 9, 2008
LOX-1 receptor blockade abrogates oxLDL-induced oxidative DNA damage and prevents activation of the transcriptional repressor Oct-1 in human coronary arterial endotheliumThomas Thum, Jürgen Borlak
Molecular Medicine (Cambridge, Mass.)|April 4, 2008
The IGF-1 receptor as a therapeutic target to improve endothelial progenitor cell functionFelix Fleissner, Thomas Thum
Circulation Research|December 6, 2003
Mechanistic role of cytochrome P450 monooxygenases in oxidized low-density lipoprotein-induced vascular injury: therapy through LOX-1 receptor antagonism?Thomas Thum, Jürgen Borlak
Pageof 50

Showing results (11-20 of 500) with videos related to

Sort By:
Pageof 50
European Heart Journal|July 2, 2020
The ESC Working Group on Myocardial FunctionThomas Thum
Nature Reviews. Cardiology|September 10, 2014
Noncoding RNAs and myocardial fibrosisThomas Thum
European Journal of Heart Failure|August 6, 2016
Novel models and mechanisms of heart failure with preserved ejection fractionThomas Thum
European Heart Journal|January 10, 2018
Refractory angina revisited: stem cells for a growing unmet clinical need?Thomas Thum
Circulation Research|December 7, 2013
MicroRNA-223 made its way into vascular researchThomas Thum
Antioxidants & Redox Signaling|August 18, 2010
Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunctionFelix Fleissner, Thomas Thum
Vascular Medicine (London, England)|February 1, 2006
Spotlight on endothelial progenitor cell inhibitors: short reviewThomas Thum, Johann Bauersachs
The Journal of Biological Chemistry|April 9, 2008
LOX-1 receptor blockade abrogates oxLDL-induced oxidative DNA damage and prevents activation of the transcriptional repressor Oct-1 in human coronary arterial endotheliumThomas Thum, Jürgen Borlak
Molecular Medicine (Cambridge, Mass.)|April 4, 2008
The IGF-1 receptor as a therapeutic target to improve endothelial progenitor cell functionFelix Fleissner, Thomas Thum
Circulation Research|December 6, 2003
Mechanistic role of cytochrome P450 monooxygenases in oxidized low-density lipoprotein-induced vascular injury: therapy through LOX-1 receptor antagonism?Thomas Thum, Jürgen Borlak
Pageof 50